Painreform Key Fundamental Indicators
| PRFX Stock | USD 3.02 0.18 5.63% |
As of the 12th of February 2026, Painreform holds the Coefficient Of Variation of (1,354), variance of 54.19, and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.
Painreform's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Painreform's valuation are provided below:We have found one hundred twenty available trending fundamental ratios for Painreform, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Painreform recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
At this time, Painreform's Research Development is fairly stable compared to the past year. Total Operating Expenses is likely to rise to about 17.7 M in 2026, whereas Depreciation And Amortization is likely to drop slightly above 13.7 K in 2026. Painreform | Select Account or Indicator | Build AI portfolio with Painreform Stock |
Painreform Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Painreform Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Painreform Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Painreform Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Painreform Fundamental Market Drivers
Painreform Upcoming Events
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Painreform Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Painreform is extremely important. It helps to project a fair market value of Painreform Stock properly, considering its historical fundamentals such as Return On Equity. Since Painreform's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Painreform's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Painreform's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Painreform. Anticipated expansion of Painreform directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Painreform assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Painreform using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Painreform's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Painreform's market price to deviate significantly from intrinsic value.
It's important to distinguish between Painreform's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Painreform should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Painreform's market price signifies the transaction level at which participants voluntarily complete trades.
Painreform 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Painreform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Painreform.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Painreform on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Painreform or generate 0.0% return on investment in Painreform over 90 days. Painreform is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More
Painreform Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Painreform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Painreform upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | (8.45) | |||
| Potential Upside | 9.48 |
Painreform Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Painreform's standard deviation. In reality, there are many statistical measures that can use Painreform historical prices to predict the future Painreform's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | (0.30) |
Painreform February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 4.78 | |||
| Coefficient Of Variation | (1,354) | |||
| Standard Deviation | 7.36 | |||
| Variance | 54.19 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | (8.45) | |||
| Potential Upside | 9.48 | |||
| Skewness | 2.3 | |||
| Kurtosis | 10.76 |
Painreform Backtested Returns
Painreform maintains Sharpe Ratio (i.e., Efficiency) of -0.0412, which implies the firm had a -0.0412 % return per unit of risk over the last 3 months. Painreform exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Painreform's Risk Adjusted Performance of (0.05), variance of 54.19, and Coefficient Of Variation of (1,354) to confirm the risk estimate we provide. The company holds a Beta of 1.84, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Painreform will likely underperform. At this point, Painreform has a negative expected return of -0.31%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and price action indicator , to decide if Painreform performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.67 |
Good predictability
Painreform has good predictability. Overlapping area represents the amount of predictability between Painreform time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Painreform price movement. The serial correlation of 0.67 indicates that around 67.0% of current Painreform price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Painreform Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Painreform has a Return On Equity of -1.2765. This is 94.67% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Painreform Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Painreform's current stock value. Our valuation model uses many indicators to compare Painreform value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Painreform competition to find correlations between indicators driving Painreform's intrinsic value. More Info.Painreform is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . At this time, Painreform's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Painreform's earnings, one of the primary drivers of an investment's value.Painreform Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Painreform's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Painreform could also be used in its relative valuation, which is a method of valuing Painreform by comparing valuation metrics of similar companies.Painreform is currently under evaluation in return on equity category among its peers.
Painreform ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Painreform's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Painreform's managers, analysts, and investors.Environmental | Governance | Social |
Painreform Fundamentals
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | (1.1 M) | ||||
| Shares Outstanding | 2.01 M | ||||
| Shares Owned By Insiders | 9.39 % | ||||
| Shares Owned By Institutions | 2.45 % | ||||
| Number Of Shares Shorted | 194.93 K | ||||
| Price To Book | 0.28 X | ||||
| EBITDA | (14.55 M) | ||||
| Net Income | (14.59 M) | ||||
| Cash And Equivalents | 13.85 M | ||||
| Cash Per Share | 1.30 X | ||||
| Total Debt | 45 K | ||||
| Current Ratio | 29.02 X | ||||
| Book Value Per Share | 4.19 X | ||||
| Cash Flow From Operations | (12.62 M) | ||||
| Short Ratio | 0.68 X | ||||
| Earnings Per Share | 29.90 X | ||||
| Target Price | 12.0 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 1.87 M | ||||
| Total Asset | 4.53 M | ||||
| Retained Earnings | (56.45 M) | ||||
| Working Capital | 1.99 M | ||||
| Net Asset | 4.53 M |
About Painreform Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Painreform's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Painreform using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Painreform based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 18.4 K | 11.9 K | |
| Stock Based Compensation To Revenue | 14.54 | 12.92 | |
| Sales General And Administrative To Revenue | 46.54 | 41.37 | |
| Research And Ddevelopement To Revenue | 46.28 | 41.14 | |
| Capex To Revenue | 0.06 | 0.06 | |
| Revenue Per Share | 43.56 | 38.72 | |
| Ebit Per Revenue | (92.82) | (97.46) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.